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Abststract. Human African trypanosomiasis is often associated with an intense proliferation of B lymphocytes, 
leading to polyclonal antibody synthesis. Using a modified enzyme-linked immunosorbent assay method, we have 
found highly significant levels of circulating anti-conjugated tryptophan-like epitope antibodies in sera of patients 
with sleeping sickness. These antibodies were immunoglobulins (Ig) of the M isotype. There was no correlation 
between immunologic binding and the Ig levels found in sera of patients with human African trypanosomiasis. Higher 
antibody levels in stage II of the disease than in stage I may be related to damage to the central nervous system. The 
specificity of this immunologic binding was evaluated by 1)  comparison with that obtained with other related con- 
jugates and 2) serum titration. Anti-conjugated tryptophan-like epitope antibodies were not found in other neurologic 
diseases tested. Their involvement in this pathology remains unknown. 
The pathology of human African trypanosomiasis or 
sleeping sickness usually comprises two stages: stage I, 
during which there is no evidence of central nervous sys- 
tem (CNS) disturbances, and stage II, defined by the pres- 
ence of parasites in the CNS. Many investigators have de- 
scribed a dysfunction and a dysregulation of the immune 
system in this disease.’ A classic immunologic feature of 
human African trypanosomiasis is the production of large 
amounts of immunoglobulins (Ig), reflecting a nonspecific 
polyclonal B lymphocyte activationZ and a production of 
autoantibodies directed against antigens unrelated to those 
of the infecting parasite. Circulating autoantibodies direct- 
ed against hippocampus and hypothalamus neurons have 
been reported in sera of infected rats.3 Autoantibodies to 
the myelin structure have been describedPb An increase in 
autoantibody titers may be due to tissue antigen release as 
a result of damage to the CNS by the parasite itself or 
inflammatory reactions, or to a large stimulation of the im- 
mune s y ~ t e m . ~  Schultzberg and others reported that in the 
CNS, the trypanosomes are located in areas that have a 
poorly developed blood-brain barrier, i.e., the area postre- 
ma, pineal gland, and median eminence, which are peri- 
ventricular  organ^.^ These investigators suggested that this 
distribution may be related to clinical symptoms. The par- 
asites are also found in the ependymal cells of the choroid 
plexus and those of the ventricular c ~ a t . ~ , ~  In these areas, 
the trypanosomes destroy the ependyma cells and the su- 
praependyma plexus. A retrograde degeneration of seroto- 
ninergic neurons has also been noted.lo These serotoniner- 
gic pathways are implicated in slow-wave sleep genesis. 
The disturbances in the serotoninergic pathways could be 
due to T and B autoreactive cells, such as in other auto- 
immune mechanisms directed against endogenous, conju- 
gated, small-sized molecules as previously described.I1-l3 
In the present study, we investigated the levels of circu- 
lating autoantibodies directed against neurotransmitters of 
serotoninergic pathways and various related molecules and 
found circulating antibodies directed against tryptophan-like 
epitopes of the M isotype in sera of patients with human 
African trypanosomiasis. 
MATERIALS AND METHODS 
Human sera. Sera from 76 patients with trypanosomiasis 
(between 3 and 78 years of age) and 22 uninfected subjects 
(between 3 and 68 years of age) living in Bok0 Songho 
(Bouenza focus of the Congo) were studied. Clinical ex- 
amination, parasite detection, and serologic analysis were 
performed. 
Detection of trypaizosomes. This was performed in blood 
and lymph node fluid and, when required, in cerebrospinal 
fluid (CSF) by direct microscopic examination andlor using 
minicolumns of D E B  ce l l~ lose . ’~  
Serologic aitalysis. Antibodies directed against trypano- 
soma1 antigens were assayed in sera using an agglutination 
test and an indirect immunofluorescent testi5 
The patients were divided in two groups: group I (early 
blood lymphatic stage) and group II (late meningoencepha- 
litis stage) according to the presence of parasites and number 
of cells (early stage 5 4 cellslmm3 in the CSF and late stage 
> 4 cells/mm3). In the CSF of patients, the cells in question 
were lymphocytes and, in advanced late stages, plasma cells. 
Sera of control groups were obtained from 10 Europeans 
(mean age = 28 years), 12 Africans who lived in France for 
more than two years (mean age = 10 years), and 12 Boli- 
vians with Chagas’ disease (mean age = 25 years). 
Sera from 24 patients infected with human immunodefi- 
ciency virus-] (HIV-1) (supplied by the Department of In- 
fectious Diseases, Hopital Pellegrin, Bordeaux, France), 
classified according to the Centers for Disease Control and 
Prevention (CDC) (Atlanta, GA)16 and divided into 14 HIV- 
positive patients and 10 patients with acquired immunode- 
ficiency syndrome (AIDS), and sera from 12 patients with 
severe neurologic signs of Parkinson’s disease (supplied by 
the Department of Neurology, Hopital Pellegrin) were also 
used. All of the latter patients presented with tremors, aki- 
nesia, and rigidity and were considered as being in the ad- 
vanced stages of Parkinson’s disease. 
Conjugate synthesis. Six indoleainine molecules, tryp- 
tophan (W), 5-hydroxytrytophan (HW), 5methoxytry~to- 
phan (MW), tryptamine (T), 5-hydroxytryptamine (HT), *and 
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5-methoxytryptamine (MT) (all from Sigma, St. Louis, MO). 
and five catecholamine molecules. dopamine (DA), O-meth- 
y1 dopamine. 6-hydroxydopamine, L-dopamine. and 0- 
methyldopamine (all from Sigma) were conjugated to poly- 
peptide carrier molecules (bovine serum albumin [BSA]: 
Sigma) according to published methods.". I s  Two types of 
conjugates were synthesized using glutaraldehyde or anhy- 
dric glutaric acid. 
Glutuï-uldekyie conjirgures. Five milligrams of each hap- 
ten or 10 mg of BSA were dissolved in 1 ml of 1.5 M acetate 
buffer, pH 8. The protein solution was mixed with the hapten 
solution: then 200 p1 of 0.5 hl glutaraldehyde was added. 
The reaction was carried out at room temperature. A ye!!ow 
color and a stable pH indicated the end of the coupling re- 
action. Then, 200 pl of a I0 mhl sodium borohydride so- 
lution (Fluka. Buchs. Switzerland) was added to saturate the 
douhle bonds. At this point, the misture became translucid. 
indicating the completion of saturation. Each solution was 
then dialyzed against distilled water for 24 hr at 4°C. Insol- 
uble material was removed by centrifugation at 10.000 X g 
for 15 min. Spectral analysis of each conjugate was per- 
formed to determine the molar coupling ratio, as previously 
described by Geffard and others." These ratios ranged he- 
tween 10 and 23. 
Aìikydri~ glirtol-ic m i d  conircgares. Twenty milligrams of 
hapten was dissolved in 200 p.1 of dimethylsufoxide and SOO 
p.1 of distilled water: then 170 p.1 of 1 M NaOH and 17 mg 
of anhydrous glutaric acid were mixed with hapten solution. 
This solution was then frozen and dried. Activation of the 
carboxylic group was initiated by the rapid addition of 800 
pl of anhydrous dimethylformamide Merck. Darmstadt. 
Germany) solution containing ethylchloroformate (Fluka) di- 
luted 1/16. The mixture u'as incubated for 5 min at 4°C. A 
protein solution containing 20 mg of BSA in 2 ml of distilled 
water, and 40 (*.I of triethylamine (hlerck) was added. The 
conjugates were purified by dialysis against distilled water 
for 24 hr at 4°C. After dialysis, absorbances at 280 and 300 
nm were measured for the determination of the molar cou- 
pling ratios, which ranged between 10 and 15. 
Determination of the amounts of immunoglobulins in 
human sera. Amounts of IgG. TgA, and Igh4 were evaluated 
using an imniunonephelometric method with a BNA neph- 
elometer (Berhing, Marburg, Germany) in sera of patients 
with human African trypanosomiasis (n = 40) and controls 
(Africans from an endemic area: n = 22, healthy European 
blood donors: n = 10, Africans living in France: n = 12, 
and subjects with Chagas' disease: n = 12). 
Enzyme-linked immunosorbent assay (ELISA ). A pre- 
viously described ELISA method was adapted for our pur- 
p o s e ~ . ~ ~  Polystyrene well plates (Nunc. Roskiltie, Denmark) 
\vere coated \vitIl 100 FI of :i solution containing either an 
indoleamine or catecholamine cori-jugate or glutaraldehyde- 
treated ßSA (BSA-G) (or anhydric gluttiric acid-trcated 
BSA [SSA-AC]) at a concentration of 10 pg/nil (opti~tium 
concentl.ation) in 0.05 hl cnlhoriats buffer pH 9.6. for I6 hr 
at 4°C. After this incubation, the \vel1 plates \ v t w  tillcd v, i t h  
phu~plinte-hut'fered saline 1 PBS) coiitaining O.OSri. Tween 20 
tPB.Z;-T\\wxl). 10% gl>cecrl~I. ; i t i d  ßSA ( 5  g/L). 1'1.1~. \\ell 
plates \sere incubated ~LM-  1 tir at 37'C to s;i[ur:itr them a n d  
pre\etit the nonsprcitic hinding i i f  the Ig. The \vcll p h t e k  
were then rinsed tuice wilh I'RS- I\\ern to reii~ove tlic es- 
cess nonadsorbed compounds. The well plates were then 
filled with 200 p1 of diluted (2.000-fold) serum plus PBS- 
Tween containing BSA ( 5  g/L) and 10% glycerol. They were 
incubated at 37°C for 1 hr. Following this primary serum 
incubation, unbound antibodies were removed by two wash- 
ings with PBS-Tween. Peroxidase-conjugated immunoglob- 
ulins (200 p1) were then added to the well plates. Horserad- 
ish peroxidase-conjugated goat immunoglobulins to human 
immunoglobulins (Diagnostic Pasteur, Marnes la Coquette, 
France) were diluted (20.000-fold) with PBS-Tween contain- 
ing BSA (5 g/L). After this secondary antibodq incuhation 
( 1  hr at 37°C). unbound antibodies were removed by two 
washer; with PBS-Tween. The substrate solution for peroxi- 
dase assay was 0.04 g/L of o-phenylenediamine (Sigma) in 
0.1 M citrate-0.2 M sodium phosphate. pH 5. and 20 pl of 
hydrogen peroxide (Sigma) added just before use in 20 ml 
of substrate solution. It was added to each well and after 
incubating for I O  min in  the dark at room temperature, the 
reaction was stopped by the addition of 50 ~1 of 4 M H,SO,/ 
well. The ahsorbance in the well plates was measured at 492 
nm with a Multiskan spectrophotometer (MR hl  O: Dynatech 
Laboratories, Alexandria. VA). The specific immunologic 
binding of sera was obtained hy substracting blank values 
read on well plates coated with BSA-G (or BSA-AG) from 
experimental absorbance values. Four assays were per- 
formed for each serum sample and good reproducihility was 
obtained. 
Statistical methods. Results are expressed as the mean 
-1- SEM except when otherwise stated. Comparison between 
group means was made using the nonparametric hlann-Whit- 
ney U test ( n  < 30). A P Lalue less than 0.05 was considered 
significant. 
RESULTS 
Immunologic binding of sera from patients with hu- 
man African trypanosomiasis using tryptophan glutar- 
aldehyde or anhydric glutaric acid conjugates. Trypto- 
phan was conjugated to BSA via either glutaraldehyde or 
anhydric glutaric acid. In the initial series of experiments, 
sera from African controls living in an endemic area ( n  = 
22). patients with stage I ( n  = 24) sleeping sickness, and 
patients Lvith stage II (n = 16) sleeping sickness were ex- 
amined. For these three groups, the mean 4 SEhl absor- 
bance values reflecting anti-conjugated tryptophan-like epi- 
tope :intibodies were 0.713 & 0.082. 1.227 4 0.188, and 
1.347 -1- 0.233, respectively, for the g1ut:iraldehyde con& 
gate (W-G-BSA) and 0.018 i: 0.006. 0.013 4 0.005, and 
0.08 f. 0.037, respectiLely, for the anhydric glutaric acid 
conjugate (W-AG-BSA). For all other indnlearnine conju- 
gates coupled to BSA via anhydric glutaric acid (T-AG-BSA, 
BSA),  w e  obtained a similar reactivity to that of 
W-AG-BSA. A serum reactivity was found only  for indole- 
:imine conjugates coupled to R S A  via glutar-;ildehydc. klore- 
over, this immunologic binding was linked only  to the IgM 
¡sotype. Thus. <tidies \vere continued on only glutu altiehyde 
cc.iri.jug:ites. No binding \vas found after qiplication of the 
anti-human IgX and IgG ¡cotypes. 
Uontrc.ils esperimcnts using BSA, glut~iral~lcli~~lc (ßSA-  
GI, ur aiihgdric glutuic. acid (BSA-AG~-trc~ctcil I3SX nere 
RIT-AG-BSA, NT-AG-BSA, RíW-AG-BSA, and HW-AG- 
n 
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FIGURE 1. Titration curves of human sera on a glutaraldehyde 
tryptophan conjugate (W-G-BSA). A, patients with human African 
trypanosomiasis (n = 9). By African controls living in an endemic 
area (n = 81). C ,  African controls living in France (n = 81). Bars 
show the mean & SEM optical density (OD). 
performed. The mean 1 SEM absorbance values for patients 
and controls, respectively, were: BSA: 0.050 1 0.009 and 
0.055 -t 0.011; BSA-G: 0.114 t 0.019 and 0.075 2 0.018, 
and BSA-AG: 0.047 1 0.008 and 0.052 1 0.008. 
Determination of immunoglobulin specificity by titra- 
tion of sera from patients with human African trypano- 
somiasis. Serum titration was performed only on the glutar- 
aldehyde tryptophan conjugate (W-G-BSA) with nine sera 
from patients with human African trypanosomiasis and sera 
from 16 controls (eight Africans living in France and eight 
Africans living in an endemic area). Two-fold serial dilutions 
from 1 X were performed. Each sera was 
assayed on tryptophan conjugate (W-G-BSA) and the mean 
5 SEM optical density (OD) readings were then obtained 
for each sera group. At serum dilutions as high as 1/8,000, 
immunoreactivity was found only in trypanosomiasis sera 
(OD = 0.423 -I O.lZO), whereas no binding was found with 
control sera (Figure 1). 
Immunoglobulin levels in sera of controts and patients 
with human African trypanosomiasis. The amounts of 
IgG, IgA, and IgM in sera of patients with human African 
trypanosomiasis and controls were evaluated using a neph- 
elometric procedure. Patients with human African trypano- 
somiasis showed increased levels of IgG (21-66.2 mg/ml) 
and IgM (0.96-3 1.2 mg/mI). This was previously described 
in trypanosomiasis.20 No correlation between high antibody 
levels and IgM levels was found in sera of human African 
trypanosomiasis patients. The control group (Africans living 
to 64 X 
in an endemic area) also had high levels of IgG (15.2-27.8 
mg/ml) and IgM (1.57-10.7 mg/ml), but they were usually 
lower than in patients. The Ig increase in controls may be 
associated with other infections. 
Study of antibody recognition with indoleamine and  
catecholamine conjugates. To evaluate the best immuno- 
logic binding, we assayed sera in human African trypano- 
somiasis with six indoleamine and five catecholamine con- 
jugates coupled to BSA via glutaraldehyde. They were 
coated on well plates and sera (diluted 1/2,000) from the 
four control groups and the patients with human African 
trypanosomiasis were classified according to the stage of 
disease and tested. High anti-conjugated tryptophan epitope 
antibody levels were found in the sera of patients with hu- 
man African trypanosomiasis (Figure 2). Means with 95% 
confidence intervals (in parentheses) were 0.702 (0.617- 
0.787) for African controls living in an endemic area, 1.107 
(0.99-1.224) for patients with stage I disease, and 1.344 
(1.166-1.522) for patients with stage II disease. These an- 
tibodies were of the M isotype. Concerning other conjugates, 
a low immunoreactivity was also observed for the tryptam- 
ine conjugate (T-G-BSA) but this binding was not statisti- 
cally significant. Other tryptamine-like conjugates (HT [se- 
rotonin] [HT-G-SA] and MT [MT-G-BSA]) were examined 
but their reactivities were very low. 
Low reactivity was obtained for catecholamine conju- 
gates. No statistical difference between sera from patients 
with human African trypanosomiasis and sera from controls 
was found. For example, the mean 5 SEM absorbance val- 
ues for the dopamine conjugate @A-G-BSA) were 0.185 ? 
0.102, 0.145 1 0.049, 0.170 1 0.056, and 0.296 k 0.114, 
respectively, for the African controls living in France (n = 
lo), the African controls living in an endemic area (n = lo), 
the patients with stage I disease (n = 9), and the patients 
with stage II disease (n = 8). Results obtained with other 
catecholamine conjugates were similar to those with DA-G- 
BSA. 
Only tryptophan-like conjugates were studied further. The 
best response was obtained with W-G-BSA, followed by 
MW-G-BSA and HW-G-BSA. Analysis of results showed a 
highly significant difference between mean OD values of 
controls and those of patients for two conjugates (W-G-BSA 
and MW-G-BSA). The immunoreactivity of sera from pa- 
tients with human African trypanosomiasis was much stron- 
ger in stage II of the disease than in stage I of the disease, 
but the difference between the two was not significant. High 
levels of anti-conjugated tryptophan-like epitope antibodies 
was correlated with clinical neurologic symptoms: 8 1.18% 
of the patients with major neurologic signs or 75% of the 
patients with stage II disease had an OD value greater than 
the critical value (mean 3- 2 SD = 1.087) calculated from 
reference group controls (Africans living in an endemic area) 
(Tables 1 and 2). Results also showed that African controls 
living in an endemic area had mean absorbance values high- 
er than the other controls. 
Evaluation of the specificity of this antibody binding 
according to different pathologic processes. To evaluate 
whether circulating antibodies were specific to human Afri- 
can trypanosomiasis, we sought the presence of such anti- 
bodies of the M isotype in sera from patients with HLV in- 
fection and Parkinson's disease. We found an increased 
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FIGURE 2. Histograms shou.ing the optical density [ODI values reflecting levels of antibodies directed against glutaraldehyde trytophan- 
related molecule conjugates ¡A, W-G-BSA: B, MW-G-BSA. and C = HW-G-BSAI and a tryptamine conjugate iD, T-G-BSA) in sera from 
control groups i 1  = Europeans [n = 101: 2 = Africans living in France [n = 121: 3 = patients with Chagas' disease [n = 121: 1 = Africans 
living in an endemic area [n = 2211 and from patients with African trypanosomiasis I5 = patients Lvith stage I disease [n = 521: 6 = patients 
with stage II disease [n = 241). Sera were diluted 1/1,000. Bars show the mean and SEM. For definition of conjugates. see Materials and 
hlethods and Results. 
the hlann-Whitney U test 1. 
P < 0.05 versus Africans living in an endemic area: ** P < 0.01 versus Africans living in an endemic area [hoth by,:: z .  
immunologic response in sera from patients with human Af- 
rican trypanosomiasis (0.054 e 0.200, n = I ? )  with \V-G- 
BSX. Weak immunologic hinding was found in  sera from 
patients \vitIl other diseases. No difference \vas detected be- 
tween the two groups of HIV-infected patients. The mean * 
SEhl :intibody levels directed against \\I-G-BSA, HW-G- 
BS.4, and hI\V-G-BSX were 0.142 2 0.098. 0. I27 f 0.07 I ,  
and O. I69 2 0.077, respectively, in sera from HIV-positive 
patient.; ( n  = 14) (Figure 3,. 0.226 t- 0.053. 0. 1 I7 f 0.038. 
and O. IS 1 2 0.059. respectively, in sera from patients \vit11 
AIDS (n = 10). and 0.220 C 0.068, 0.176 2 0.030, and 
O. 143 t- 0.043, respcctivcly, in sera from p;iticnt< Lvith Par- 
kinson's disease (Figure 3) .  These data unilerlined spccific 
i t~~niunologic  biniiing ilircc[cd against tryptuplian-like COII- 
jugatss i n  Iiuman Africiiii tryPanosoiniasis w ~ .  
with human African trypanosomiasis. This immunologic 
hinding was related to the IgM isotype. We found reactivity 
of sera \vitIl the tryptophan glutaraldehyde conjugate (\\'-G- 
BSA), but not with corijugatcs made with glutaric anhydride 
acid (\Y-AG-BSA). This indicates the iinportance of the con- 
for.m:ition of the hapten adsorbed on  the well plates after 
conjugate synthesis. The presence of a carboxyl terminal 
grnup in tryptophan conjugates is an impnrtant element for 
;ìntibody recugnition hecause tryptamine conjugates, \vhich 
liuve an amino terminal group, are poorly rectignized (Figure 
2). 
Imrnuriologic binding to ~lutaraldehyJe-tr);ptophan con- 
jugates n a s  evaluated :tnd a line:lr decrense i n  OD indicated 
the specificity of thc Ig from p:itients \villi human African 
t q  Ixinosmiiasis (Figure 1 ). Africans living in  an endziiiic 
a i a  had anti-ccinjug;itcci tryptoplxiii-lihe upitope antibciJ\l 
Ie\t.l.; higher than othcr contr~ls. Xfricaiis living in  this en- 
dcii.iic :irea tniglit II;I\ .C been previ~iusly infectcd unci tlicti 
c i i r d ,  tryji;iiiîisi~iii~-iiitcctrci but uiitictcc1sd, or  txiircrs c > f  
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FIGURE 3. Mean and SEM antibody levels directed against glu- 
taraldehyde tryptophan-related conjugates (A, W-G-BSA, B, HW-G- 
BSA, and C, MW-G-BSA) in sera from 1, European controls; 2, 
human immunodeficiency virus-positive patients; 3, patients with 
Parkinson's disease; and 4, patients with human African trypano- 
somiasis. Sera were diluted 112,000. Bars show the mean and SEM 
optical density (OD). Sera from the first three groups did not bind 
any tryptophan conjugates compared with sera from patients with 
human African trypanosomiasis. ** = 0.01, by the Mann-Whitney 
b, 
U test. 'J.* 
other parasites resulting in increased anti-conjugated tryp- 
tophan-like epitope antibody levels. The presence of a faint 
immunologic signal in European controls or Africans living 
in France could be a physiologic signal linked to the pres- 
ence of a few autoantibodies in normal subjects or a back- 
ground signal of the ELISA. We measured the Ig of serum 
and observed no correlation between the amount of IgM in 
sera from patients with human African trypanosomiasis and 
TABLE 1
Correlation bemeen disease stage and aizti-conjugated, tryptophan- 
like ailtibodies found in controls and in patients with trypanoso- 
miasis detected by an enzyme-linked inu~~unosorbent assay using 
tryptophan-glutaraldelzyde-bovine serum albuinin conjugate 
No. > crit- 
OD ical value* 
(%)t 
Controls (Africans in France) 12 0.417 f 0.212 O (O) 
Controls (Africans in endemic 
area) 22 0.703 t 0.192 O (O) 
Early stage (I) of disease 52 1.107 2 0.443 23 (44.2) 
Late stage (II) of disease 24 1.344 & 0.4242 18 (75) 
living in an endemic area. 
value. 
n (mean & SD) Subjects 
*The critical value is the mean t 2 SD optical density (OD) reading of African controls 
t Percentage of patients having a mean OD reading greater than or equal to the critical 
increased antibody levels. This agrees with the Ig specificity. 
Classification of sera from patients with human African try- 
panosomiasis according to the stage of disease and clinical 
symptoms showed an immunologic signal that was higher in 
the Iate stage than in the first stage and a significant corre- 
lation between high antibody levels and neurologic symp- 
toms (Tables 1 and 2).  
The increase of circulating autoantibodies in patients with 
human African trypanosomiasis is probably dependent on 
polyclonal B cell activation, but it may reflect an additional 
specific stimulation by autoantigens or by cross-reacting an- 
tigens.6 High antibody titers against myelin basic protein, 
cerebrosides, and gangliosides have been found in murine 
experimental African trypanosomiasis."' Antibodies to my- 
elin components (galactocerebrosides) have been found in 
sera of humans with African trypanosomiasis? Low titers of 
naturally occurring anti-galactocerebroside antibodies have 
been reported in the sera of healthy humans, compared with 
higher titers observed in patients with human African try- 
panosomiasis.4 These antibodies may contribute to the patho- 
logic consequences observed. Also, experimental demyelin- 
ization has been induced by injection of anti- 
galactocerebroside antibodies.22 Similar mechanisms have 
been proposed to explain the pathologic aspects of South 
American trypano~omiasis.~~ A comparison between immu- 
nologic binding in sera of patients with human African try- 
panosomiasis and other neurologic diseases shows a selec- 
TABLE 2 
Correlation between clinical symptoms and anti-conjugated typto- 
phan-like antibodies found in controls and in patients with try- 
panosomiasis detected by an enzyme-linked ìinmunosorbent assay 
usirzg tryptop~7an-glldtaraldeliyde-bovine seruin albuniin cotdugate 
No. 2 crit- 
OD ical value' 
Subjects n (mean t SD) (%It 
Controls (Africans in France) 12 0.417 _t 0.212 O (O) 
Controls (Africans in endemic area) 22 0.703 2 0.192 O (O) 
Patients without clinical symptoms 35 1.031 & 0.452 15 (42.8) 
Patients with minor clinical symp- 
toms 30 1.241 k 0.385 19 (63.3) 
Patients with major neurologic 
symptoms 11 1.470 f 0.465 9 (81.8) 
*The critical value is the nlean f 2 SD optical density (OD) reilding of African ControIs 
7 Percentage of patients having a mean OD reading greater than or equal Io the critical 
living in an endemic arca. 
value. 
. . , . . , . . . . . I . .  I . I .  " _ L .  
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tive increase of anti-conjugated tryptophan antibody levels 
only in the sera of patients with human African trypanoso- 
miasis (Figure 3) .  
Indoleamine compounds are largely distributed in the 
CNS.'4 Serotonin (HT) is a major neurotransmitter invohed 
in the control of numerous CNS functions. including ag- 
gressive and self-injurious behavior, regulation of sleep 
states and psychiatric disorders. including schizophrenia. and 
depression.25 Tryptophan is the natural amino acid precursor 
in HT biosynthesis. It has previously been stated that HW. 
the first metabolite deriving directly from tryptophan, could 
be considered to be a putative neurotransmitter that may play 
a role in  the regulation of the sleep/wake cycle.2h ?' More- 
over. some studies have indicated the presence of a specific 
binding of HW to membrane receptors.2h Thus. the multi- 
plicity of HT receptors could be related to members of the 
indoleamine family. such as HW and tryptophan itself. In 
rat and human brains. the choroid plexus has larger amounts 
of HT-lihe receptors compared with other regions such as 
the pallidum or substantia nigra.?' Supra-ependymal nerve 
terminals derived from serotoninergic cells have their origin 
in the raphe nuclei.'" Serotonin nerve terminals are present 
on the walls of the ventricles and they could release HT into 
the CSE During sleeping sickness, ependyma cells and the 
supraependymal plexus are destroyed by parasites.lcl Anti- 
bodies directed against tryptophan-like conjugates could 
play a role in the pathophysiology of the disease or could 
merely be a sign of tissue degradation devoid of effects. 
Their pathologic role in this disease, if any. will be clarified 
by further studies. 
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